Short-chain fatty acids regulate cytokines and Th17/treg cells in human peripheral blood mononuclear cells in vitro

Immunological Investigations

Volumn 45, Issue 3, 2016, Pages 205-222

  Asarat, M ^a   Apostolopoulos, V ^a   Vasiljevic, T ^a   Donkor, O ^a  

^a VICTORIA UNIVERSITY   (Australia)

Author keywords

Acetate; butyrate; cytokines; human peripheral blood mononuclear cells; propionate; short chain fatty acids; T helper cells; Th17 and CD4+CD25+ Treg cells

Indexed keywords

ACETIC ACID; BUTYRIC ACID; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROPIONIC ACID; TRANSFORMING GROWTH FACTOR BETA1; MEMBRANE ANTIGEN; VOLATILE FATTY ACID;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELL STIMULATION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH17 CELL; UPREGULATION; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MONONUCLEAR CELL; PHENOTYPE; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, SURFACE; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; FATTY ACIDS, VOLATILE; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; NITRIC OXIDE; PHENOTYPE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84961644246     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2015.1122613     Document Type: Article

References (80)

1. Adom D, Nie D. (2013). Regulation of autophagy by short chain fatty acids in colon cancer cells. In Autophagy-A Double-Edged Sword-Cell Survival or Death? edited by Yannick Bailly., 235-247. ISBN: 978-953-51-1062-0, InTech, doi: 10.5772/54999. http://www.intechopen.com/books/autophagy-a-double-edged-sword-cell-survival-or-death-/regulation-of-autophagy-by-short-chain-fatty-acids-in-colon-cancer-cells.
2. Aoyama M, Kotani J, Usami M. (2010). Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. Nutrition, 26 (6), 653-61. doi: http://dx.doi.org/10.1016/j.nut.2009.07.006.
3. Arpaia, N, Campbell C, Fan X, et al. (2013). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature, 504 (7480), 451-5.
4. Bailon E, Cueto-Sola M, Utrilla P, et al. (2010). Butyrate in vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis. Immunobiology, 215 (11), 863-73.
5. Bassaganya-Riera J, DiGuardo M, Viladomiu M, et al. (2011). Soluble fibers and resistant starch ameliorate disease activity in interleukin-10-deficient mice with inflammatory bowel disease. J Nutr, 141 (7), 1318-25. doi: 10.3945/jn.111.139022.
6. Bindels LB, Dewulf EM, Delzenne NM. (2013). GPR43/FFA2: Physiopathological relevance and therapeutic prospects. Trends Pharmacol Sci, 34 (4), 226-32.
7. Bogdan, C. (2001). Nitric oxide and the immune response. Nat Immunol, 2 (10), 907-16.
8. Brand S. (2009). Crohns disease: Th1, Th17 or both? The change of a paradigm: New immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohns disease. Gut, 58 (8), 1152-67. doi: 10.1136/gut.2008.163667.
9. Brown AJ, Goldsworthy SM, Barnes AA, et al. (2003). The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem, 278 (13), 11312-19. doi: 10.1074/jbc.M211609200.
10. Campbell DJ, Koch MA. (2011). Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol, 11 (2), 119-30. doi: 10.1038/nri2916.
11. Cavaglieri CR, Nishiyama A, Fernandes LC, et al. (2003). Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci, 73 (13), 1683-90. doi: http://dx.doi.org/10.1016/S0024-3205(03)00490-9.
12. Chen J, Bruns AH, Donnelly HK, Wunderink RG. (2010). Comparative in vitro stimulation with lipopolysaccharide to study TNFalpha gene expression in fresh whole blood, fresh and frozen peripheral blood mononuclear cells. J Immunol Methods, 357(1-2), 33-7.
13. Chovanova L, Vlcek M, Krskova K, et al. (2013). Increased production of IL-6 and IL-17 in lipopolysaccharide-stimulated peripheral mononuclears from patients with rheumatoid arthritis. Gen Physiol Biophys, 32(3), 395-404.
14. Cox MA, Jackson J, Stanton M, et al. (2009). Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol: WJG, 15 (44), 5549-57.
15. Cummings JH, Macfarlane G.T. (1991). The control and consequences of bacterial fermentation in the human colon. J Appl Microbiol, 70 (6), 443-59. doi: 10.1111/j.1365-2672.1991.tb02739.x.
16. Cummings JH, Pomare EW, Branch WJ, et al. (1987). Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut, 28 (10), 1221-7.
17. Davie JR. (2003). Inhibition of histone deacetylase activity by butyrate. J Nutr, 133 (7), 2485S-2493S.
18. de Jong E, Suddason T, Lord GM. (2010). Translational mini-review series on Th17 cells: Development of mouse and human T helper 17 cells. Clin Exp Immunol, 159 (2), 148-58. doi: 10.1111/j.1365-2249.2009.04041.x.
19. Dionne S, Ruemmele FM, Seidman EG. (2004). Immunopathogenesis of inflammatory bowel disease: role of cytokines and immune cell-enterocyte interactions. In: Bistrian BR, Walker-Smith JA, eds. Inflammatory bowel diseases. Basel, Switzerland: Karger, 41-62.
20. Donkor ON, Ravikumar M, Proudfoot O, et al. (2012). Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure. Clin Exp Immunol, 167 (2), 282-95. doi: 10.1111/j.1365-2249.2011.04496.x.
21. Furusawa Y, Obata Y, Fukuda S, et al. (2013). Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature, 504 (7480), 446-50.
22. Gálvez J. (2014). Role of Th17 cells in the pathogenesis of human IBD. Int Schol Res Not, 2014, 1-14.
23. Hijova E, Chmelarova A. (2007). Short chain fatty acids and colonic health. Bratislava Med J, 108 (8), 354.
24. Hoeppli RE, Wu D, Cook L, Levings MK. (2015). The environment of regulatory T cell biology: Cytokines, metabolites, and the microbiome. Front Immunol, 6, 1-14.
25. Iwakura Y, Ishigame H. (2006). The IL-23/IL-17 axis in inflammation. J Clin Invest, 116 (5), 1218.
26. Jansky L, Reymanova P, Kopecky J. (2003). Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia. Physiol Res, 52 (6), 593-8.
27. Ji L, Zhan Y, Hua F, et al. (2012). The ratio of Treg/Th17 cells correlates with the disease activity of primary immune thrombocytopenia. PLoS ONE, 7 (12), e50909. doi: 10.1371/journal.pone.0050909.
28. Kimura A, Kishimoto T. (2010). IL-6: Regulator of Treg/Th17 balance. Eur J Immunol, 40 (7), 1830-5. doi: 10.1002/eji.201040391.
29. Korn T, Bettelli E, Oukka M, Kuchroo VK. (2009). IL-17 and Th17 Cells. In Annual Review of Immunology, 485-517. Palo Alto: Annual Reviews.
30. Korn T, Oukka M, Kuchroo V, Bettelli E. (2007) Th17 cells: Effector T cells with inflammatory properties. Semina Immunol, 19 (6), 362-71. doi: 10.1016/j.smim.2007.10.007.
31. Kurita-Ochiai T, Fukushima K, Ochiai K. (1999). Lipopolysaccharide stimulates butyric acid-induced apoptosis in human peripheral blood mononuclear cells. Infect Immun, 67 (1), 22-9.
32. Le Poul E, Loison C, Struyf S, et al. (2003). Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem, 278 (28), 25481-9. doi: 10.1074/jbc.M301403200.
33. Liu T, Li J, Liu Y, et al. (2012). Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-kappaB pathway in RAW264.7 cells. Inflammation 35 (5), 1676-84. doi: 10.1007/s10753-012-9484-z.
34. Luckheeram RV, Zhou R, Verma AD, Xia B. (2012). CD4+T Cells: Differentiation and functions. Clin Dev Immunol, 2012, 12. doi: 10.1155/2012/925135.
35. Luhrs H, Gerke T, Boxberger F, et al. (2001). Butyrate inhibits interleukin-1-mediated nuclear factor-kappa B activation in human epithelial cells. Digestive Dis Sci, 46 (9), 1968-73.
36. Martich GD, Boujoukos AJ, Suffredini AF. (1993). Response of man to endotoxin. Immunobiology 187(3-5), 403-16.
37. Maslowski KM, Vieira AT, Ng A, et al. (2009). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, 461 (7268), 1282-6. doi: http://www.nature.com/nature/journal/v461/n7268/suppinfo/nature08530-S1.html.
38. Masui R, Sasaki M, Funaki Y, et al. (2013). G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells. Inflamm Bowel Dis, 19 (13), 2848-56. doi: 10.1097/01.MIB.0000435444.14860.ea.
39. Matsumoto N, Riley S, Fraser D, et al. (2006). Butyrate modulates TGF-β1 generation and function: Potential renal benefit for Acacia (sen) SUPERGUM™(gum arabic)? Kidney Int, 69 (2), 257-65.
40. Meijer K, de Vos P, Priebe MG. (2010). Butyrate and other short-chain fatty acids as modulators of immunity: What relevance for health? Curr Opin Clin Nutr Metab Care, 13 (6), 715-21. doi: 10.1097/MCO.0b013e32833eebe5.
41. Minoprio P. (2000). Lymphocytes: A practical approach (2nd edn) by S.L. Rowland-Jones and A.J. McMichel." Parasitology Today 16 (. 8), 360. doi: http://dx.doi.org/10.1016/S0169-4758(00)01726-9.
42. Nancey S, Bienvenu J, Coffin B, et al. (2002). Butyrate strongly inhibits in vitro stimulated release of cytokines in blood. Digestive Dis Sci, 47 (4), 921-8.
43. National Health and Medical Research Council,. Australian Research Council, and. Australian Vice-Chancellors Committee. (2007). National Statement on Ethical Conduct in Human Research-Updated March 2014. edited by National Health and Medical Research Council. Canberra, Australia. National Health and Medical Research Council.
44. Plebanski M. (2000). Preparation of lymphocytes and identification of lymphocytes subpopulations. In Lymphocytes: A Practical Approach., edited by Sarah L. Rowland-Jones and Andrew J. McMichael., 1-26. Oxford: Oxford University Press.
45. Ramachandran H, Laux J, Moldovan I, et al. (2012). Optimal thawing of cryopreserved peripheral blood mononuclear cells for use in high-throughput human immune monitoring studies. Cells, 1 (3), 313-24.
46. Ramgolam VS, Sha Y, Jin J, et al. (2009). IFN-β inhibits human Th17 cell differentiation. J Immunol, 183 (8), 5418-27. doi: 10.4049/jimmunol.0803227.
47. Rodríguez-Cabezas ME, Galvez J, Lorente MD, et al. (2002). Dietary fiber down-regulates colonic tumor necrosis factor α and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. J Nutr, 132 (11), 3263-71.
48. Roy CC, Kien CL, Bouthillier L, Levy E. (2006). Short-chain fatty acids: ready for prime time? Nutr Clin Pract, 21 (4), 351-66.
49. Sanchez-Capelo A. (2005). Dual role for TGF-beta1 in apoptosis. Cytokine Growth Factor Rev, 16 (1), 15-34. doi: 10.1016/j.cytogfr.2004.11.002.
50. SAS/STAT. 1996. SAS/STAT® Software: Changes and enhancements: Through Release 6.11, SAS Institute Cary, North Carolina.
51. Saulnier DMA, Spinler JK, Gibson GR, Versalovic J. (2009). Mechanisms of probiosis and prebiosis: Considerations for enhanced functional foods. Curr Opin Biotechnol, 20 (2), 135-41. doi: 10.1016/j.copbio.2009.01.002.
52. Scheppach W. (1994). Effects of short chain fatty acids on gut morphology and function. Gut, 35 (1 Suppl), S35-8.
53. Segain JP, Raingeard de la Bletiere D, Bourreille A, et al. (2000). Butyrate inhibits inflammatory responses through NFkappaB inhibition: Implications for Crohns disease. Gut, 47 (3), 397-403.
54. Sellin JH. (1999). SCFAs: The enigma of weak electrolyte transport in the colon. News Physiol Sci, 14, 58-64.
55. Shajarian M, Alsahebfosoul F, Etemadifar M, et al. (2015). IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects. Immunol Invest, (0), 1-9.
56. Sharif O, Bolshakov VN, Raines S, et al. (2007). Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunology 8, 1.
57. Sharma JN, Al-Omran A, Parvathy SS. (2007). Role of nitric oxide in inflammatory diseases. Inflammopharmacology, 15 (6), 252-9.
58. Taira J, Nanbu H, Ueda K. (2009). Nitric oxide-scavenging compounds in Agrimonia pilosa Ledeb on LPS-induced RAW264. 7 macrophages. Food Chem, 115 (4), 1221-7.
59. Taylor A, Verhagen J, Blaser K, et al. (2006). Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: The role of T regulatory cells. Immunology, 117 (4), 433-42. doi: 10.1111/j.1365-2567.2006.02321.x.
60. Tedelind S, Westberg F, Kjerrulf M, Vidal A. (2007). Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease. World J Gastroenterol, 13 (20), 2826-32.
61. Topping DL, Clifton PM. (2001). Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides. Physiol Rev, 81 (3), 1031-64.
62. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, et al. (2009). The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe, 5 (4), 329-40.
63. Vernia P, Marcheggiano A, Caprilli R, et al. (1995). Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther, 9 (3), 309-13.
64. Vinolo MA, Rodrigues HG, Hatanaka E, et al. (2011a). Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem, 22 (9), 849-55. doi: 10.1016/j.jnutbio.2010.07.009.
65. Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. (2011b). Regulation of inflammation by short chain fatty acids. Nutrients, 3 (10), 858-76. doi: 10.3390/nu3100858.
66. Waldecker M, Kautenburger T, Daumann H, et al. (2008). Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem, 19 (9), 587-93. doi: http://dx.doi.org/10.1016/j.jnutbio.2007.08.002.
67. Wan YY, Flavell RA. (2009). How diverse-CD4 effector T cells and their functions. J Mol Cell Biol, 1 (1), 20-36.
68. Wang C, Kang SG, Lee JH, Kim CH. (2009). CCR6 regulates the migration and effector function of Th17 cells in the gut. J Immunol, 182(Meeting Abstracts 1), 96.2.
69. Weber TE, Kerr BJ. (2006). Butyrate differentially regulates cytokines and proliferation in porcine peripheral blood mononuclear cells. Vet Immunol Immunopathol, 113 (1), 139-47.
70. Witkin SS, Alvi S, Bongiovanni AM, et al. (2011). Lactic acid stimulates interleukin-23 production by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide. FEMS Immunol Med Microbiol, 61 (2), 153-8.
71. Yang L, Anderson DE, Baecher-Allan C, et al. (2008). IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature, 454 (7202), 350-2. doi: 10.1038/nature07021.
72. Yin L, Laevsky G, Giardina C. (2001). Butyrate suppression of colonocyte NF-B activation and cellular proteasome activity. J Biol Chem, 276 (48), 44641-6. doi: 10.1074/jbc.M105170200.
73. Yoshimura A, Suzuki M, Sakaguchi R, et al. (2012). SOCS, inflammation and autoimmunity. Front Immunol, 3. doi: 10.3389/fimmu.2012.00020.
74. Zheng SG. (2013). Regulatory T cells vs Th17: Differentiation of Th17 versus Treg, are the mutually exclusive? Am J Clin Exp Immunol, 2 (1), 94-106.
75. Zhou L, Chong MMW, Littman DR. (2009). Plasticity of CD4+ T cell lineage differentiation. Immunity, 30 (5), 646-55.
76. Zhou L, Ivanov II, Spolski R, et al. (2007). IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol, 8 (9), 967-74.
77. Zhou L, Lopes JE, Chong MM, et al. (2008). TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature, 453 (7192), 236-40. doi: 10.1038/nature06878.
78. Zhu J, Yamane H, Paul WE. (2010). Differentiation of effector CD4 T cell populations∗. Ann Rev Immunol, 28, 445-89. doi: 10.1146/annurev-immunol-030409-101212.
79. Ziegler SF, Buckner JH. (2009). FOXP3 and the regulation of Treg/Th17 differentiation. Microbes Infect, 11 (5), 594-8. doi: 10.1016/j.micinf.2009.04.002.
80. Ziolkowska M, Koc A, Luszczykiewicz G, et al. 2000. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol, 164 (5), 2832-8.